The hSynC – Cell Engineering Product provides a potentially revolutionary next generation technology to provide transformative cell therapy treatments for human genetic diseases. This means a number of possible application areas that could open-up for the technology allowing for numerous collaboration opportunities alongside high value licensing opportunities.
Applications in the areas of immune-oncology, metabolic diseases and neuromuscular are areas of high interest.
For further information, we invite you to link into www.cgbioengineering.com for more information.
